Divi's Laboratories Limited

NSE DIVISLAB.NS

Divi's Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 265,472,042

Divi's Laboratories Limited Shares (Diluted, Weighted) is 265,472,042 for the year ending March 31, 2024, a 0.00% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Divi's Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 265,468,579, a 0.00% change year over year.
Divi's Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 265,468,579, a 0.00% change year over year.
Divi's Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 265,468,579, a 0.00% change year over year.
Divi's Laboratories Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 265,468,579, a -0.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: DIVISLAB.NS

Divi's Laboratories Limited

CEO	Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
IPO Date	March 12, 2003
Location	India
Headquarters	Divi Towers
Employees	9,741
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Key trends

Past 5 years